EA201071324A1 - Система и способы измерения профилей биомаркеров - Google Patents

Система и способы измерения профилей биомаркеров

Info

Publication number
EA201071324A1
EA201071324A1 EA201071324A EA201071324A EA201071324A1 EA 201071324 A1 EA201071324 A1 EA 201071324A1 EA 201071324 A EA201071324 A EA 201071324A EA 201071324 A EA201071324 A EA 201071324A EA 201071324 A1 EA201071324 A1 EA 201071324A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
biomarkers
measuring profiles
profiles
measuring
Prior art date
Application number
EA201071324A
Other languages
English (en)
Inventor
Ирина Антониевич
Джозеф Тамм
Роман Артимишин
Кристоф П.Г. Жеральд
Ян Бастхольм Вистисен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA201071324A1 publication Critical patent/EA201071324A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Изобретение относится к способам и системам для диагностики пациентов с аффективными расстройствами. Способы также могут применяться для прогнозирования восприимчивости к аффективному расстройству у субъекта.
EA201071324A 2008-08-27 2009-08-27 Система и способы измерения профилей биомаркеров EA201071324A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9227008P 2008-08-27 2008-08-27
PCT/US2009/055144 WO2010025216A1 (en) 2008-08-27 2009-08-27 System and methods for measuring biomarker profiles

Publications (1)

Publication Number Publication Date
EA201071324A1 true EA201071324A1 (ru) 2011-12-30

Family

ID=41721907

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201071324A EA201071324A1 (ru) 2008-08-27 2009-08-27 Система и способы измерения профилей биомаркеров

Country Status (10)

Country Link
US (1) US20110172501A1 (ru)
EP (1) EP2318551A4 (ru)
JP (1) JP2012501181A (ru)
KR (1) KR20110057188A (ru)
CN (1) CN102224256A (ru)
AU (1) AU2009285766A1 (ru)
BR (1) BRPI0914859A2 (ru)
CA (1) CA2728171A1 (ru)
EA (1) EA201071324A1 (ru)
WO (1) WO2010025216A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8655807B2 (en) * 2010-04-05 2014-02-18 Applied Research Associates, Inc. Methods for forming recognition algorithms for laser-induced breakdown spectroscopy
US8676739B2 (en) * 2010-11-11 2014-03-18 International Business Machines Corporation Determining a preferred node in a classification and regression tree for use in a predictive analysis
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
KR101483284B1 (ko) * 2013-01-31 2015-01-15 한국과학기술원 질병 관련 단일염기다형성 조합 추출 방법, 질병 발생 위험도 예측 방법, 그리고 이를 이용한 질병 발생 위험도 예측 장치
US20160209428A1 (en) * 2013-08-21 2016-07-21 The Regents Of The University Of California Diagnostic and predictive metabolite patterns for disorders affecting the brain and nervous system
WO2022187670A1 (en) * 2021-03-05 2022-09-09 University Of North Texas Health Science Center At Fort Worth Personalized medicine approach for treating cognitive loss
AU2014354808A1 (en) 2013-11-26 2016-06-02 University Of North Texas Health Science Center At Fort Worth Personalized medicine approach for treating cognitive loss
US9545227B2 (en) * 2013-12-13 2017-01-17 Vital Connect, Inc. Sleep apnea syndrome (SAS) screening using wearable devices
WO2017082103A1 (ja) * 2015-11-12 2017-05-18 国立大学法人九州大学 うつ病診断用バイオマーカー及びその使用
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
AU2018206460A1 (en) * 2017-01-08 2019-08-15 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Systems and methods for using supervised learning to predict subject-specific bacteremia outcomes
WO2018160841A1 (en) 2017-03-01 2018-09-07 Genentech, Inc. Diagnostic and therapeutic methods for cancer
TWI640018B (zh) * 2017-03-15 2018-11-01 長庚醫療財團法人林口長庚紀念醫院 Data integration method
JP7170250B2 (ja) * 2017-07-07 2022-11-14 パナソニックＩｐマネジメント株式会社 情報提供方法、情報処理システム、及び情報処理方法
CN110268383A (zh) * 2017-11-13 2019-09-20 多发性骨髓瘤研究基金会公司 综合、分子、组学、免疫疗法、代谢、表观遗传学和临床数据库
CA3019970A1 (en) * 2018-10-05 2020-04-05 Fang Liu Methods for diagnosing or treating post-traumatic stress disorder, and compositions therefor
US11537888B2 (en) * 2019-05-15 2022-12-27 The Florida International University Board Of Trustees Systems and methods for predicting pain level
CN113210264B (zh) * 2021-05-19 2023-09-05 江苏鑫源烟草薄片有限公司 烟草杂物剔除方法及装置

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US5958688A (en) * 1997-04-28 1999-09-28 The Trustees Of The University Of Pennsylvania Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US20070178475A1 (en) * 1998-09-17 2007-08-02 Nehls Michael C Novel human polynucleotides and polypeptides encoded thereby
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
DE10019058A1 (de) * 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
DE60226429D1 (de) * 2001-02-27 2008-06-19 Brni Neurosciences Inst Diagnose der alzheimer-krankheit auf basis von mitogenaktivierter proteinkinase-phosphorylierung
JP3771502B2 (ja) * 2002-02-14 2006-04-26 国立大学法人 新潟大学 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
WO2004007762A2 (en) * 2002-07-11 2004-01-22 Novartis Ag Genes associated with schizophrenia, adhd and bipolar disorders
JP2004135667A (ja) * 2002-09-27 2004-05-13 Japan Science & Technology Agency 血液を用いた統合失調症の診断方法
JP2004208547A (ja) * 2002-12-27 2004-07-29 Hitachi Ltd うつ病の評価方法
US20040248286A1 (en) * 2003-03-21 2004-12-09 Christine Konradi Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
EP1636376A2 (en) * 2003-06-13 2006-03-22 The Babraham Institute Differential gene expression in schizophrenia
US20050069936A1 (en) * 2003-09-26 2005-03-31 Cornelius Diamond Diagnostic markers of depression treatment and methods of use thereof
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
US20050208519A1 (en) * 2004-03-12 2005-09-22 Genenews Inc. Biomarkers for diagnosing schizophrenia and bipolar disorder
JP2005312435A (ja) * 2004-03-29 2005-11-10 Kazuhito Rokutan うつ病の評価方法
US20090081243A1 (en) * 2004-06-03 2009-03-26 Athlomics Pty Ltd. Agents and methods for diagnosing stress
US8415298B2 (en) * 2004-06-21 2013-04-09 The Board Of Trustees Of The Leland Stanford Junior University Of Stanford Administration of FGF2 for treamtent of anxiety
US7736621B2 (en) * 2004-08-03 2010-06-15 Hypatia Ltd. Methods for gauging the effect of a depression treatment by determining the levels of beta-arrestin 1 and G-protein coupled receptor kinase 2
WO2006097244A2 (en) * 2005-03-17 2006-09-21 F. Hoffman-La Roche Ag Methods for assessing emphysema
US20070122395A1 (en) * 2005-10-06 2007-05-31 Vanderbilt University Genetic and pharmacological regulation of antidepressant-sensitive biogenic amine transporters through PKG/p38 map kinase
US7906281B2 (en) * 2005-10-07 2011-03-15 The Regents Of The University Of California Method to predict the response to lithium treatment
WO2007044094A1 (en) * 2005-10-11 2007-04-19 Blanchette Rockefeller Neurosciences Institute Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
US20080033598A1 (en) * 2006-03-23 2008-02-07 Hollingsworth Stephen A Materials management system and method
US20070292880A1 (en) * 2006-05-05 2007-12-20 Robert Philibert Compositions and methods for detecting predisposition to a substance use disorder or to a mental illness or syndrome
WO2007136797A1 (en) * 2006-05-18 2007-11-29 The Mclean Hospital Corporation Methods for diagnosis and prognosis of psychotic disorders
EP2044431B1 (en) * 2006-07-17 2019-04-24 H. Lee Moffitt Cancer Center & Research Institute, Inc. Computer systems and methods for selecting subjects for clinical trials
RU2473555C2 (ru) * 2006-12-19 2013-01-27 ДжинГоу, Инк. Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных
US20100256001A1 (en) * 2007-04-03 2010-10-07 The Scripps Research Institute Blood biomarkers for mood disorders
WO2008144371A1 (en) * 2007-05-16 2008-11-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for diagnosing suicidal tendencies

Also Published As

Publication number Publication date
AU2009285766A1 (en) 2010-03-04
US20110172501A1 (en) 2011-07-14
CN102224256A (zh) 2011-10-19
WO2010025216A9 (en) 2010-11-18
EP2318551A4 (en) 2012-10-24
KR20110057188A (ko) 2011-05-31
EP2318551A1 (en) 2011-05-11
CA2728171A1 (en) 2010-03-04
WO2010025216A1 (en) 2010-03-04
BRPI0914859A2 (pt) 2015-11-03
JP2012501181A (ja) 2012-01-19

Similar Documents

Publication Publication Date Title
EA201071324A1 (ru) Система и способы измерения профилей биомаркеров
NZ735173A (en) Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders
IL254062B (en) Kits containing ptk7 antibody and their use in the treatment, detection, diagnosis or monitoring of cancer
EA201590027A1 (ru) Способы детекции заболеваний или состояний
CY1120434T1 (el) Πρωτεϊνες προσδεσης il-1
AR098155A1 (es) Métodos para diagnosticar y tratar trastornos eosinofílicos
BR112014007485A2 (pt) biomarcadores preditivos de sensibilidade a tratamento com ativador de receptor de acetilcolina nicotínico alfa 7
BR112013021590A2 (pt) detecção de capacitância em ensaio eletroquímico com resposta otimizada
IN2014MN00318A (ru)
BR112013012501A2 (pt) método e sistema de teste de analito com notificação de tendências de analito altas e baixas
BR112013006683A2 (pt) diagnóstico de câncer de mama
IN2014DN08537A (ru)
TW201129817A (en) Real-time data with post-processing
EP2313761A4 (en) SYSTEMS AND METHOD FOR THE OPTICAL MEASUREMENT OF ANALYZ CONCENTRATION
IN2014CN04326A (ru)
EP2756313A4 (en) METHOD AND KITS FOR DETECTING AND MONITORING DIAGNOSTIC BIOMARKERS FOR POSTTRAUMATIC LOAD DISORDER (PTSD) AND DISTINCTION BETWEEN SUICID AND NON-SUCCIDANT FORMS OF DISORDER
EA201201085A1 (ru) Фосфолипидное профилирование и рак
BR112015013771A2 (pt) biomarcador preditivo de resposta ao tratamento de ativador do receptor alfa 7 nicotínico de acetilcolina
BR112012002954A2 (pt) metodo para diagnosticar um disturbio de tireoide, metodo para determinar a capacidade de um composto de induzir um disturbio da tireoide metodo para identificar uma substancia para tratar um disturbio da tireoide, dispositivo para diagnosticar um disturbio da tireoide e uso de pelo menos um analito
BRPI0912210A2 (pt) dispositivo para medição e gerenciamento de analito e métodos associados
EP2835643A4 (en) METHOD FOR DETECTING OR QUANTITATING ANALYSTS, KIT FOR DETECTING OR QUANTIFYING ANALYSTS AND TEST STRIPS FOR SIDEFLOW CHROMATOGRAPHY FOR DETECTING OR QUANTIFYING ANALYTES
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
IN2012DN03817A (ru)
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.